Compared with no treatment, xenon-augmented hypothermia reduced cerebral MRS abnormalities and cell death markers in some brain regions. Compared with hypothermia, xenon-augmented hypothermia did not reach statistical significance for any measure. The safety and possible improved efficacy support phase II trials.

No abstract

A mild and environment-friendly strategy of copper-catalyzed regioselective hydroboration of terminal alkynes in aqueous medium was developed.